AMERICAN SHARED HOSPITAL SER (AMS) Fundamental Analysis & Valuation

NYSEARCA:AMS • US0295951059

Current stock price

1.5 USD
+0.21 (+16.28%)
At close:
1.56 USD
+0.06 (+4%)
After Hours:

This AMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AMS Profitability Analysis

1.1 Basic Checks

  • AMS had negative earnings in the past year.
  • In the past year AMS had a positive cash flow from operations.
  • AMS had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years AMS had a positive operating cash flow.
AMS Yearly Net Income VS EBIT VS OCF VS FCFAMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • With a Return On Assets value of -2.80%, AMS is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
  • AMS has a Return On Equity of -6.46%. This is comparable to the rest of the industry: AMS outperforms 43.00% of its industry peers.
Industry RankSector Rank
ROA -2.8%
ROE -6.46%
ROIC N/A
ROA(3y)0.7%
ROA(5y)1.11%
ROE(3y)1.64%
ROE(5y)2.4%
ROIC(3y)N/A
ROIC(5y)N/A
AMS Yearly ROA, ROE, ROICAMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • Looking at the Gross Margin, with a value of 18.03%, AMS is doing worse than 60.00% of the companies in the same industry.
  • AMS's Gross Margin has declined in the last couple of years.
  • AMS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.82%
GM growth 5Y-6.37%
AMS Yearly Profit, Operating, Gross MarginsAMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AMS Health Analysis

2.1 Basic Checks

  • AMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AMS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AMS has been increased compared to 5 years ago.
  • The debt/assets ratio for AMS has been reduced compared to a year ago.
AMS Yearly Shares OutstandingAMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
AMS Yearly Total Debt VS Total AssetsAMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that AMS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AMS (0.53) is worse than 74.00% of its industry peers.
  • There is no outstanding debt for AMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.53
ROIC/WACCN/A
WACC8.96%
AMS Yearly LT Debt VS Equity VS FCFAMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • AMS has a Current Ratio of 0.76. This is a bad value and indicates that AMS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AMS has a Current ratio of 0.76. This is amonst the worse of the industry: AMS underperforms 84.00% of its industry peers.
  • A Quick Ratio of 0.76 indicates that AMS may have some problems paying its short term obligations.
  • AMS has a worse Quick ratio (0.76) than 79.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
AMS Yearly Current Assets VS Current LiabilitesAMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. AMS Growth Analysis

3.1 Past

  • AMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.55%.
  • Looking at the last year, AMS shows a decrease in Revenue. The Revenue has decreased by -0.91% in the last year.
  • The Revenue has been growing by 9.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y12.45%
Revenue growth 5Y9.5%
Sales Q2Q%-14.79%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMS Yearly Revenue VS EstimatesAMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AMS Yearly EPS VS EstimatesAMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. AMS Valuation Analysis

4.1 Price/Earnings Ratio

  • AMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMS Price Earnings VS Forward Price EarningsAMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AMS is valued cheaper than 89.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.04
AMS Per share dataAMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMS Dividend Analysis

5.1 Amount

  • No dividends for AMS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMS Fundamentals: All Metrics, Ratios and Statistics

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (4/16/2026, 4:31:50 PM)

After market: 1.56 +0.06 (+4%)

1.5

+0.21 (+16.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-31
Earnings (Next)05-07
Inst Owners13.39%
Inst Owner Change0%
Ins Owners35.73%
Ins Owner Change0%
Market Cap9.90M
Revenue(TTM)28.08M
Net Income(TTM)-1.55M
Analysts80
Price Target4.59 (206%)
Short Float %0.05%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.22%
Min Revenue beat(2)-12.86%
Max Revenue beat(2)-5.58%
Revenue beat(4)0
Avg Revenue beat(4)-5.84%
Min Revenue beat(4)-12.86%
Max Revenue beat(4)-0.96%
Revenue beat(8)3
Avg Revenue beat(8)0.24%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF 3.2
P/B 0.41
P/tB 0.44
EV/EBITDA 6.04
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)0.47
OCFY31.29%
SpS4.25
BVpS3.64
TBVpS3.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.8%
ROE -6.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.03%
FCFM N/A
ROA(3y)0.7%
ROA(5y)1.11%
ROE(3y)1.64%
ROE(5y)2.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.82%
GM growth 5Y-6.37%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 133.6%
Cap/Sales 27.18%
Interest Coverage N/A
Cash Conversion 83.73%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 0.53
F-Score4
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)127.88%
Cap/Depr(5y)85.08%
Cap/Sales(3y)28.2%
Cap/Sales(5y)19.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y12.45%
Revenue growth 5Y9.5%
Sales Q2Q%-14.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-213.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1755.09%
OCF growth 3Y-24.64%
OCF growth 5Y-20.49%

AMERICAN SHARED HOSPITAL SER / AMS Fundamental Analysis FAQ

What is the fundamental rating for AMS stock?

ChartMill assigns a fundamental rating of 2 / 10 to AMS.


What is the valuation status for AMS stock?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN SHARED HOSPITAL SER (AMS). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN SHARED HOSPITAL SER?

AMERICAN SHARED HOSPITAL SER (AMS) has a profitability rating of 2 / 10.